• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Scorecard on Medicare Payment Reform

Article

An independent review of Medicare payments reveals that 42% of the healthcare dollars Medicare paid to providers in its fee-for-service program in 2013 were designed to boost the value of care patients receive.

An independent review of Medicare payments reveals that 42% of the healthcare dollars Medicare paid to providers in its fee-for-service program in 2013 were designed to boost the value of care patients receive. Catalyst for Payment Reform (CPR), a nonprofit coalition of employers and other healthcare purchasers pushing for better value in healthcare, released the findings today in its Scorecard on Medicare Payment Reform, the first such analysis of the billions of dollars Medicare pays to healthcare providers.

CPR’s Scorecard comes on the heels of an announcement by HHS that it has set ambitious goals for increasing the proportion of Medicare payments designed to improve the value of care patients receive. HHS goals include tying 50% of traditional, or fee-for-service, Medicare payments to quality or value by the end of 2018 through alternative payment models. CPR’s groundbreaking review of Medicare payments will provide a baseline against which to track value-oriented Medicare payments going forward.

Read the press release: http://bit.ly/1KeHdpQ

Related Videos
Kimberly Westrich, MA, chief strategy officer, National Pharmaceutical Council
Chicago skyline with words "CHEST 2025 Recap Chicago, Illinois" | Image credit: SeanPavonePhoto - stock.adobe.com
Andrew Wolf, MD, assistant professor of neurology, University of Colorado Anschutz
Dr Brian Mulherin
Dr Brian Mulherin
Lindsey Valenzuela, PharmD, APh, BCACP - screenshot by AJMC
Robert Andrews, former US representative for New Jersey and CEO of the Health Transformation Alliance
Robert Andrews, chief executive officer, Health Transformation Alliance
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.